ICICI Prudential Life Insurance: Gets Approval To Rename Itself To 'ICICI Life Insurance'

AARTI PHARMA: Q1 EBITDA 1.36B RUPEES VS 952M (YOY) || Q1 EBITDA MARGIN 25.40% VS 24.66% (YOY)

AARTI PHARMA: Q1 REVENUE 5.36B RUPEES VS 3.86B (YOY)

AARTI PHARMA: Q1 CONS NET PROFIT 761M RUPEES VS 460M (YOY)

BHARAT WIRE ROPES: Q1 EBITDA 255M RUPEES VS 301M (YOY) || Q1 EBITDA MARGIN 19.68% VS 21.26% (YOY)

BHARAT WIRE ROPES: Q1 REVENUE 1.3B RUPEES VS 1.4B (YOY)

BHARAT WIRE ROPES: Q1 SL NET PROFIT 122M RUPEES VS 156M (YOY)

SYSTEMATIX CORPORATE SERVICES: Q1 REVENUE 589M RUPEES VS 394M (YOY)

SYSTEMATIX CORPORATE SERVICES: Q1 CONS NET LOSS 49M RUPEES VS PROFIT 105M (YOY)

CELLO WORLD: Q1 EBITDA 990M RUPEES VS 1.09B (YOY) || Q1 EBITDA MARGIN 18.80% VS 20.61% (YOY)

CELLO WORLD: Q1 REVENUE 5.26B RUPEES VS 5.29B (YOY)

CELLO WORLD: Q1 CONS NET PROFIT 734M RUPEES VS 730M (YOY)

PASUPATI ACRYLON: Q1 EBITDA 387M RUPEES VS 57M (YOY) || Q1 EBITDA MARGIN 16.26% VS 2.64% (YOY)

PASUPATI ACRYLON: Q1 REVENUE 2.4B RUPEES VS 2.16B (YOY)

PASUPATI ACRYLON: Q1 SL NET PROFIT 274M RUPEES VS 18M (YOY)

SADHANA NITROCHEM: Q1 REVENUE 262M RUPEES VS 281M (YOY)

SADHANA NITROCHEM: Q1 CONS NET LOSS 4M RUPEES VS -17M (YOY)